MacroGenics | MGNX - Interest Expense On Debt


MacroGenics reported $4.89M in Interest Expense on Debt for its fiscal quarter ending in March of 2026.





Interest Expense On Debt Change Date
AbbVie USD 645M 69M Mar/2026
Amgen USD 95.64B 94.98B Jun/2026
AstraZeneca USD 340M 144M Jun/2026
Biogen USD 72.6M 12.6M Jun/2025
Bristol-Myers Squibb USD 407M 4M Jun/2026
Daiichi Sankyo JPY 3.57B 1.4B Mar/2026
Eli Lilly USD 114.7M 134.3M Sep/2025
Genmab DKK 10M 27M Dec/2025
Geron USD 7.15M 150K Mar/2026
Gilead Sciences USD 247M 7M Jun/2026
J&J USD 43M 25M Mar/2026
Karyopharm Therapeutics USD 12.55M 66K Mar/2026
MacroGenics USD 4.89M 1.55M Mar/2026
Merck USD 525M 46M Jun/2026
Pfizer USD 667M 4M Jun/2026
Puma Biotechnology USD 3.37M 11K Jun/2024
Regeneron Pharmaceuticals USD 11M 1.9M Jun/2026
Roche Holding CHF 304M 7.5M Jun/2025
Xencor USD 4.7M 2.65M Mar/2026